Medacta Group 관리
관리 기준 확인 3/4
현재 CEO에 대한 정보가 충분하지 않습니다.
주요 정보
Francesco Siccardi
최고 경영자
€1.9m
총 보상
| CEO 급여 비율 | 21.3% |
| CEO 임기 | 6yrs |
| CEO 소유권 | 19.9% |
| 경영진 평균 재임 기간 | 11.3yrs |
| 이사회 평균 재임 기간 | 5.8yrs |
최근 관리 업데이트
Recent updates
The Price Is Right For Medacta Group SA (VTX:MOVE)
Nov 22
Is Medacta Group (VTX:MOVE) A Risky Investment?
Oct 14Medacta Group SA (VTX:MOVE) Shares Could Be 32% Above Their Intrinsic Value Estimate
Sep 06What Does Medacta Group SA's (VTX:MOVE) Share Price Indicate?
Aug 21Medacta Group (VTX:MOVE) Is Reinvesting At Lower Rates Of Return
Aug 06Medacta Group SA's (VTX:MOVE) P/E Still Appears To Be Reasonable
Jun 20We Discuss Why Medacta Group SA's (VTX:MOVE) CEO Will Find It Hard To Get A Pay Rise From Shareholders This Year
May 01Medacta Group (VTX:MOVE) Has A Pretty Healthy Balance Sheet
Apr 17Is Now An Opportune Moment To Examine Medacta Group SA (VTX:MOVE)?
Mar 29Does Medacta Group (VTX:MOVE) Deserve A Spot On Your Watchlist?
Feb 22Medacta Group (VTX:MOVE) Will Be Hoping To Turn Its Returns On Capital Around
Feb 07Getting In Cheap On Medacta Group SA (VTX:MOVE) Might Be Difficult
Dec 18Calculating The Intrinsic Value Of Medacta Group SA (VTX:MOVE)
Dec 04Is Now The Time To Look At Buying Medacta Group SA (VTX:MOVE)?
Nov 15Returns On Capital Signal Tricky Times Ahead For Medacta Group (VTX:MOVE)
Oct 30If EPS Growth Is Important To You, Medacta Group (VTX:MOVE) Presents An Opportunity
Oct 17Is Medacta Group (VTX:MOVE) Using Too Much Debt?
Sep 29Calculating The Intrinsic Value Of Medacta Group SA (VTX:MOVE)
Aug 11Is Now The Time To Look At Buying Medacta Group SA (VTX:MOVE)?
Jul 27Be Wary Of Medacta Group (VTX:MOVE) And Its Returns On Capital
Jul 03At CHF117, Is It Time To Put Medacta Group SA (VTX:MOVE) On Your Watch List?
Apr 28Is Medacta Group (VTX:MOVE) A Risky Investment?
Apr 08Is Now An Opportune Moment To Examine Medacta Group SA (VTX:MOVE)?
Dec 25Capital Allocation Trends At Medacta Group (VTX:MOVE) Aren't Ideal
Dec 09Does Medacta Group (VTX:MOVE) Have A Healthy Balance Sheet?
Nov 09Why Medacta Group SA (VTX:MOVE) Could Be Worth Watching
Sep 16The Returns On Capital At Medacta Group (VTX:MOVE) Don't Inspire Confidence
Aug 20Here's Why Medacta Group (VTX:MOVE) Has Caught The Eye Of Investors
Jul 02Should You Think About Buying Medacta Group SA (VTX:MOVE) Now?
May 28Medacta Group (VTX:MOVE) Is Reinvesting At Lower Rates Of Return
May 12These 4 Measures Indicate That Medacta Group (VTX:MOVE) Is Using Debt Reasonably Well
Mar 31Does Medacta Group (VTX:MOVE) Deserve A Spot On Your Watchlist?
Mar 17Capital Investments At Medacta Group (VTX:MOVE) Point To A Promising Future
Feb 07Should You Investigate Medacta Group SA (VTX:MOVE) At CHF133?
Dec 10Medacta Group (VTX:MOVE) Knows How To Allocate Capital
Nov 05Here's Why Medacta Group (VTX:MOVE) Can Manage Its Debt Responsibly
Sep 30Is It Too Late To Consider Buying Medacta Group SA (VTX:MOVE)?
Aug 26Medacta Group (VTX:MOVE) May Have Issues Allocating Its Capital
Jul 20Should You Investigate Medacta Group SA (VTX:MOVE) At CHF119?
May 19We Think Medacta Group (VTX:MOVE) Can Stay On Top Of Its Debt
Apr 05What You Need To Know About Medacta Group SA's (VTX:MOVE) Investor Composition
Mar 02Is Medacta Group SA's (VTX:MOVE) 7.6% ROE Better Than Average?
Feb 02The Medacta Group (VTX:MOVE) Share Price Has Gained 24% And Shareholders Are Hoping For More
Jan 12
Returns On Capital At Medacta Group (VTX:MOVE) Paint An Interesting Picture
Dec 21Should You Use Medacta Group's (VTX:MOVE) Statutory Earnings To Analyse It?
Dec 03CEO 보상 분석
| 날짜 | 총 보상 | 급여 | 회사 수익 |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | €56m |
| Mar 31 2024 | n/a | n/a | €52m |
| Dec 31 2023 | €2m | €396k | €47m |
| Sep 30 2023 | n/a | n/a | €49m |
| Jun 30 2023 | n/a | n/a | €50m |
| Mar 31 2023 | n/a | n/a | €48m |
| Dec 31 2022 | €2m | €372k | €46m |
| Sep 30 2022 | n/a | n/a | €47m |
| Jun 30 2022 | n/a | n/a | €47m |
| Mar 31 2022 | n/a | n/a | €49m |
| Dec 31 2021 | €2m | €354k | €52m |
| Sep 30 2021 | n/a | n/a | €54m |
| Jun 30 2021 | n/a | n/a | €57m |
| Mar 31 2021 | n/a | n/a | €47m |
| Dec 31 2020 | €1m | €339k | €37m |
| Sep 30 2020 | n/a | n/a | €24m |
| Jun 30 2020 | n/a | n/a | €10m |
| Mar 31 2020 | n/a | n/a | €11m |
| Dec 31 2019 | €843k | €247k | €12m |
보상 대 시장: Francesco 의 총 보상 ($USD 1.95M )은 Swiss 시장( $USD 1.47M ).
보상과 수익: Francesco 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.
CEO
Francesco Siccardi (47 yo)
6yrs
테뉴어
€1,861,824
보상
Dr. Francesco Siccardi has been Chief Executive Officer of Medacta Group SA since November 1, 2018. He is a Member of the Board of Directors of Surgical Practice Resource Group SA, Lugano since 2015 and of...
리더십 팀
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| Founder & Non Executive Chairman | 6.8yrs | €352.21k | 10.18% CHF 220.2m | |
| Chief Executive Officer | 6yrs | €1.86m | 19.88% CHF 429.9m | |
| Chief Financial Officer | 13.8yrs | 데이터 없음 | 데이터 없음 | |
| Senior Director of Global Marketing | no data | 데이터 없음 | 데이터 없음 | |
| Chief People Officer | no data | 데이터 없음 | 데이터 없음 | |
| Chief Supply Chain Officer | 8.8yrs | 데이터 없음 | 19.78% CHF 427.8m | |
| Head of IT | no data | 데이터 없음 | 데이터 없음 | |
| Chief Commercial Officer | no data | 데이터 없음 | 데이터 없음 | |
| Chief Innovation Officer | no data | 데이터 없음 | 데이터 없음 | |
| Secretary of the Board | no data | 데이터 없음 | 데이터 없음 | |
| Group Vice President of Finance & Tax | no data | 데이터 없음 | 데이터 없음 |
11.3yrs
평균 재임 기간
51.5yo
평균 연령
경험이 풍부한 관리: MOVE 의 관리팀은 노련하고 경험 (평균 재직 기간 11.3 년)입니다.
이사회 구성원
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| Founder & Non Executive Chairman | 6.8yrs | €352.21k | 10.18% CHF 220.2m | |
| Lead Independent Director | 5.8yrs | €231.19k | 0.013% CHF 271.0k | |
| Independent Director | 3.9yrs | €128.89k | 0.16% CHF 3.5m | |
| Independent Director | 5.7yrs | €152.33k | 데이터 없음 | |
| Non-executive Director | 6.8yrs | €137.62k | 19.78% CHF 427.8m |
5.8yrs
평균 재임 기간
64yo
평균 연령
경험이 풍부한 이사회: MOVE 의 이사회는 경험(평균 재직 기간 5.8 년)으로 간주됩니다.